IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays.
Publication/Presentation Date
3-1-2015
Abstract
In 2011, the IFCC Task Force on Clinical Applications of Cardiac Bio-Markers (TF-CB) was formed, with the purpose of providing evidence based educational materials to assist all biomarker users, i.e. laboratorians, clinicians, researchers, in-vitro diagnostics and regulatory agencies, in better understanding important analytical and clinical aspects of established and novel cardiac biomarkers for use in clinical practice and research. The goal of the task force was to promulgate the same information conjointly through the in vitro diagnostic industry to the laboratory, emergency department and cardiologists. The initial undertaking of the TF-CB, which is comprised of laboratory medicine scientists, emergency medicine physicians and cardiologists, was to address two key issues pertaining to implementing high-sensitivity cardiac troponin (hs-cTn) assays in clinical practice: the 99th percentile upper reference limit (URL) and calculating serial change values in accord with the Universal Definition of AMI. The highlights of both concepts from IFCC statements are described.
Volume
48
Issue
4-5
First Page
201
Last Page
203
ISSN
1873-2933
Published In/Presented At
Apple, F. S., Jaffe, A. S., Collinson, P., Mockel, M., Ordonez-Llanos, J., Lindahl, B., Hollander, J., Plebani, M., Than, M., Chan, M. H., & International Federation of Clinical Chemistry (IFCC) Task Force on Clinical Applications of Cardiac Bio-Markers (2015). IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clinical biochemistry, 48(4-5), 201–203. https://doi.org/10.1016/j.clinbiochem.2014.08.021
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
25204966
Department(s)
Administration and Leadership
Document Type
Article